The previous page is sending you to http://www.prnewswire.com/news-releases/nektar-initiates-phase-1-clinical-study-evaluating-nktr-181-a-novel-opioid-molecule-for-treatment-of-pain-118355429.html.

 If you do not want to visit that page, you can return to the previous page.